Mensali N, Joaquina S, de Montlaur C, Casey NP, Nesset TO, Myklebost O, McCormack E, Pasetto A, Gunnes MW, Gelebart P, Inderberg EM, Wälchli S (2026)
Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
Cytotherapy, 28 (12), 102930 (in press)
DOI 10.1016/j.jcyt.2026.102930, PubMed 42854615

Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Villatoro A, Dougé A, Krpina K, Schmitz LM, Forcados C, Kaveh F, Arias-Díaz AE, Gelebart P, McCormack E, Stripecke R, Abal M, Davidson B, Inderberg EM, Wälchli S (2026)
Combining TAG-72CAR with anti-MUC16CAR improves the potency of ovarian cancer treatment
FEBS J (in press)
DOI 10.1111/febs.70760, PubMed 42834815